Ketoprofen-liposomes formulation for clinical therapy

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 10, 2012, Pages 2499-2507

  Tarţaǎu, Liliana ^a   Cazacu, Ana ^b   Melnig, V ^b  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC ACTIVITY; ANTINOCICEPTIVE EFFECT; AVERAGE DIAMETER; CHITOSAN MOLECULE; CLINICAL THERAPY; DIALYZED SOLUTIONS; IN-VITRO; IN-VIVO; KETOPROFEN; MAXIMUM INTENSITIES; PHOSPHATIDYLCHOLINE; POSITIVE CHARGES; PROLONGED RELEASE; RETARDATION EFFECT; STERIC EFFECT; VESICLES FORMATION;

BIOLOGICAL MATERIALS; SYSTEM STABILITY;

LIPOSOMES;

ANALGESIC AGENT; CHITOSAN; KETOPROFEN; PHOSPHATIDYLCHOLINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG FORMULATION; DYNAMICS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; KETOPROFEN; LIPOSOMES; MICE; PAIN;

EID: 84867354563     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4712-5     Document Type: Conference Paper

References (25)

1. Dudley GA, Czerkawski J, Meinrod A, Gillis G, Baldwin A, Scarpone M. Efficacy of naproxen sodium for exercise induced dysfunction muscle injury and soreness. Clin J Sport Med. 1997;10:3-10.
2. Predel HG, Koll R, Pabst H, Dieter R, Gallacchi G, Giannetti B, Bulitta M, Heidecker JL, Mueller EA. Diclofenac patch for topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Br J Sports Med. 2004;38:318-23.
3. Iwama T. NSAIDs and colorectal cancer prevention. J Gastroenterol. 2009;44:72-6.
4. McCarthy M. Comparative toxicity of nonsteroidal anti-inflammatory drugs. Am J Med. 2000;107:37-46.
5. Lemke TL, Williams DA, Roche VF, Zito SW. Foye's principles of medical chemistry. 6th ed. Philadelphia: Wolter Kluwer; 2008.
6. Mathew ST, Devi SG, Prasanth VV, Vinod B. Formulation and in vitro-in vivo evaluation of ketoprofen-loaded albumin microspheres for intramuscular administration. J Microencapsul. 2009;26:456-69.
7. Del Gaudio P, Russo P, Lauro MR, Colombo P, Aquino RP. Encapsulation of ketoprofen and ketoprofen lysinate by prilling for controlled drug release. AAPS Pharm Sci Tech. 2009;10:1178-85.
8. ® RS and RL: study of the manufacturing parameters. Drug Develop Ind Pharm. 2008;34:1178-87.
9. Rajesh KS, Bhowmik BB, Sa B. Effect of polyvinylpyrrolidone on physical characteristics of ketoprofen-loaded polystryrene microparticles. Indian J Pharm Sci. 2003;65:526-9.
10. Tan TW, Hu B, Jin XH, Zhang M. Release behavior of ketoprofen from chitosan/alginate microcapsules. J Bioact Compat Polym. 2003;18:207-18.
11. Barauskas J, Johnsson M, Tiberg F. Self-assembled lipid superstructures: beyond vesicles and liposomes. Nano Lett. 2005;5:1615-9.
12. Discher DE, Eisenberg A. Polymer vesicles. Science. 2002;29:7967-73.
13. Soussan E, Cassel S, Blanzat M, Rico-Lattes I. Drug delivery by soft matter: matrix and vesicular carriers. Angew Chem Int Ed. 2008;48:274-88.
14. Garlea A, Popa MI, Pohoata V, Melnig V. Ibuprofen/ketoprofen entrapment in chitosan based vesicle carrier. Rom J Biophys. 2007;17:157-68.
15. Garlea A, Melnig V, Popa MI. Nanostructured chitosansurfactant matrices as polyphenols nanocapsules template with zero order release kinetics. J Mater Sci, Mater Med. 2010;21:1211-23.
16. Tiyaboonchai W. Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ J. 2003;11:51-66.
17. Riddick TM. Control of colloid stability through zeta potential. New York: Zetameter Inc; 1968.
18. Keefe FJ, Fillingim RB, Williams DA. Behavioral assessment of pain: nonverbal measures in animals and humans. ILAR J. 1991;33:3-13.
19. Walker EA, Butelman ER, DeCosta BR, Woods JH. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther. 1993;267:280-6.
20. Shin JW, Hwang KS, Kim YK, Leem JG, Lee C. Nonsteroidal antiinflammatory drugs suppress pain-related behaviors, but not referred hyperalgesia of visceral pain in mice. Anaesth Analg. 2006;102:195-200.
21. Winters WD, Hance AJ, Cadd GG, Quam DD. Acetic acid for analgesic screening. J Pharmacol Exp Therapeut. 2003;244:51-7.
22. Hamza M, Dionne RA. Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Curr Mol Pharmacol. 2009;2:1-14.
23. Pinardi G, Sierralta F, Miranda HF. Adrenergic mechanisms in antinociceptive effects of non steroidal anti-inflammatory drugs in acute thermal nociception in mice. Inflamm Res. 2002;51:219-22.
24. Mishra S, Suryawanshi R, Chawla V, Saraf S. Fabrication and characterization of solid lipid microparticles of ketoprofen. Ars Pharm. 2011;52:12-5.
25. Girard P, Verniers D, Coppé MC, Pansart Y. Nefopam and ketoprofen synergy in rodent models of antinociception. Eur J Pharmacol. 2008;584:263-71.